α-Galactosyl FP20 A86780 (Previously 860780) 6-O-α-D-Galactopyranosyl-1β,2N,3-tridodecanoyl-D-glucosamine-4-phosphate, sodium salt
α-Galactosyl FP-20 is a glycosylated fusion peptide (FP) adjuvant that targets human Toll-like receptor 4 (hTLR4) to activate intracellular signaling pathways. With this compound's inclusion of an α-galactose group, this structural analog of FP‑20 sodium salt has enhanced immunomodulatory specificity and receptor targeting precision.
Engineered for reliable, large-scale synthesis, α-Galactosyl FP-20 is optimal for innovative vaccine adjuvant research studies, especially those that require accurate, efficacious hTLR4 targeting and fine-tuned immune responses.
